1208229-58-6
1208229-58-6
Chemical Structure
Tepilamide fumarate
Synonym(s): XP-23829; PPC-06
- CAS No.: 1208229-58-6
- Formula:C11H17NO5
- Molecular Weight:243.26
IUPAC Name: 2-(diethylamino)-2-oxoethyl methyl fumarate
InChIKey: AKUGRXRLHCCENI-VOTSOKGWSA-N
SMILES: O=C(OCC(N(CC)CC)=O)/C=C/C(OC)=O
Biological Activity: Tepilamide fumarate (XP-23829; PPC-06) is an oral fumaric acid ester, acts as a proagent ofMonomethyl fumarate (HY-103252), and is used in the research of moderate to severe chronic plaque psoriasis. Tepilamide fumarate can enhance the effectiveness of oncolytic viruses[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Tepilamide fumarate | 99.77% | Tepilamide fumarate (XP-23829; PPC-06) is an oral fumaric acid ester, acts as a proagent ofMonomethyl fumarate (HY-103252), and is used in the research of moderate to severe chronic plaque psoriasis. Tepilamide fumarate can enhance the effectiveness of oncolytic viruses. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Tepilamide fumarate (Standard) | ≥98% | Tepilamide fumarate (Standard) is the analytical standard of Tepilamide fumarate (HY-109105). This product is intended for research and analytical applications. Tepilamide fumarate (XP-23829; PPC-06) is an oral fumaric acid ester, acts as a proagent ofMonomethyl fumarate (HY-103252), and is used in the research of moderate to severe chronic plaque psoriasis. Tepilamide fumarate can enhance the effectiveness of oncolytic viruses. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Mrowietz U, et al. Tepilamide Fumarate (PPC-06) Extended Release Tablets in Patients with Moderate-to-Severe Plaque Psoriasis: Safety and Efficacy Results from the Randomized, Double-blind, Placebo-controlled AFFIRM Study. J Clin Aesthet Dermatol. 2022 Jan;15(1):53-58. [Content Brief]
- [2]. Akram Alwithenani, et al. Tepilamide Fumarate as a Novel Potentiator of Virus-Based Therapy. Viruses. 2024 Jun 5;16(6):920. [Content Brief]
